Bernard Horowitz

Bernard Horowitz appears in our data through filings on Omrix Biopharmaceuticals, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 24 April 2006 to 4 September 2008, the count stands at 9 filings.

On the open market, the record shows 3 purchases worth €31k and 1 sale worth €51k. On balance, insiders were net sellers of €20k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 2 share grants and 2 option exercises.

In size, the median ticket on the buying side is €11k.

Most recently, on 5 September 2008, the filings show a share grant in Omrix Biopharmaceuticals, Inc. The clock since the last published purchase (17 May 2006) now reads 7,465 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.